- Reagents & Consumables
- Software & Systems
- Services
Gene Editing Market size was valued at USD 5,028.6 million in 2022 and is poised to grow at a significant CAGR of 16.1% over 2023-2029. Gene editing has shown potential in the therapy of genetic abnormalities, infectious illnesses, and cancer. Gene editing is a sort of genetic editing in which a DNA sequence is inserted, removed, or altered in an organism's genome to cure a specific condition using a designed nuclease or molecular scissor. The CRISPR segment is anticipated to grow at a significant CAGR over the forecast years owing to increased government and private investment, increased demand for and acceptance of CRISPR, and technology developments Individual investigator grants, government, and commercial enterprise, such as research projects and program awards that are projected to improve the market are frequently used to support the development of CRISPR technology. Continuous technological advancements in gene-editing tools is a major factor driving the growth of the market.
Gene Editing Market Key Developments:
- In June 2021, Allele Biotechnology and Alpine BioTherapeutics Corporation announced an agreement for developing induced pluripotent stem cells for treatment of retinal diseases. This strategy assisted the company in developing advanced product portfolio.
- In May 2020, Caribou Science entered into a commercial and clinical license agreement with MaxCyte. The deal was aimed to gain exclusive rights to use MaxCyte’s flow electroporation technology and the ExPERT platform. This is slated to advance Caribou’s gene-edited allogeneic T cell therapy programs and expand their corporate relations in the market.
Gene Editing Market Summary
Study Period
2023-29
Base Year
2022
CAGR
16.1%
Largest Market
Asia Pacific
Fastest Growing Market
North America
Gene Editing Market Dynamics
Genome editing has shown promise in the treatment of genetic abnormalities, infectious illnesses, and cancer. Cancer and other hereditary disorders are becoming more widespread, and customised care is getting more popular. Many governments are increasing funding and grants to assist genome editing research in their countries/regions. Because of the advantages of genome editing, several governments are funding public and private research, as well as academic institutes, to expand genome editing and genetic engineering research. For instance, In March 2020, Genome Canada received USD 15 million from the Ministry of Innovation, Science, and Industry (Science) to fund 11 genomic research initiatives in the health, agricultural, and environment sectors. Provincial governments, industries, and research partners will contribute a total of USD 29.7 million to these research projects.
Asia-Pacific Got Significant Share
Gene Editing Market Regional Analysis
The global gene editing market in Asia pacific is likely to hold the highest revenue share of in 2021 and same trend is expected over the forecast period due to growing number of research firms in emerging markets will enhance the regional industrial environment. The development of gene editing technology by major corporations will boost regional industrial growth. Furthermore, increased R&D activity in Japan, China, and India will accelerate regional market trends.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The gene editing market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Gene Editing Market Segmentation
By Product Type
By Technology
- CRISPR
- TALEN
- ZFN
- Others
By Application
- Cell Line Engineering
- Genetic Engineering
- Diagnostic Applications
- Drug Discovery & Development
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
Frequently Asked Questions
The gene editing market size was valued at USD 5,028.6 million in 2022
CRISPR Therapeutics, Thermo Fisher Scientific, Inc., Integrated DNA Technologies, Inc.
The gene editing market segments are by product type, technology, application and end user
| 1. Executive Summary |
| 2. Global Gene Editing Market Introduction |
| 2.1. Global Gene Editing Market – Taxonomy |
| 2.2. Global Gene Editing Market – Definitions |
| 2.2.1. Product Type |
| 2.2.2. Technology |
| 2.2.3. Application |
| 2.2.4. Region |
| 3. Global Gene Editing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Current Trends |
| 3.5. Global Gene Editing Market Dynamic Factors - Impact Analysis |
| 3.6. Mergers, Acquisitions, and Collaborations |
| 4. Global Gene Editing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Gene Editing Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Reagents & Consumables |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Software & Systems |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Services |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Gene Editing Market, By Technology, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1. CRISPR |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. TALEN |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. ZFN |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Antisense |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Gene Editing Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. Cell Line Engineering |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Genetic Engineering |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Applications |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Drug Discovery & Development |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Gene Editing Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. Pharmaceutical and Biotechnology Companies |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Academic and Research Institutes |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Contract Research Organizations |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Gene Editing Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. MEA |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, and Country, 2023 - 2029 |
| 10. North America Gene Editing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Reagents & Consumables |
| 10.1.2. Software & Systems |
| 10.1.3. Services |
| 10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. CRISPR |
| 10.2.2. TALEN |
| 10.2.3. ZFN |
| 10.2.4. Antisense |
| 10.2.5. Others |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Cell Line Engineering |
| 10.3.2. Genetic Engineering |
| 10.3.3. Diagnostic Applications |
| 10.3.4. Drug Discovery & Development |
| 10.3.5. Others |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. Pharmaceutical and Biotechnology Companies |
| 10.4.2. Academic and Research Institutes |
| 10.4.3. Contract Research Organizations |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1. United States |
| 10.5.2. Canada |
| 10.6. North America Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2023 - 2029 |
| 10.7. North America Gene Editing Market Dynamics – Trends |
| 11. Europe Gene Editing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Reagents & Consumables |
| 11.1.2. Software & Systems |
| 11.1.3. Services |
| 11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. CRISPR |
| 11.2.2. TALEN |
| 11.2.3. ZFN |
| 11.2.4. Antisense |
| 11.2.5. Others |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Cell Line Engineering |
| 11.3.2. Genetic Engineering |
| 11.3.3. Diagnostic Applications |
| 11.3.4. Drug Discovery & Development |
| 11.3.5. Others |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Pharmaceutical and Biotechnology Companies |
| 11.4.2. Academic and Research Institutes |
| 11.4.3. Contract Research Organizations |
| 11.5. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1. UK |
| 11.5.2. Germany |
| 11.5.3. France |
| 11.5.4. Italy |
| 11.5.5. Spain |
| 11.5.6. Rest of Europe |
| 11.6. Europe Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2023 - 2029 |
| 11.7. Europe Gene Editing Market Dynamics – Trends |
| 12. Asia Pacific Gene Editing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Reagents & Consumables |
| 12.1.2. Software & Systems |
| 12.1.3. Services |
| 12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. CRISPR |
| 12.2.2. TALEN |
| 12.2.3. ZFN |
| 12.2.4. Antisense |
| 12.2.5. Others |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Cell Line Engineering |
| 12.3.2. Genetic Engineering |
| 12.3.3. Diagnostic Applications |
| 12.3.4. Drug Discovery & Development |
| 12.3.5. Others |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. Pharmaceutical and Biotechnology Companies |
| 12.4.2. Academic and Research Institutes |
| 12.4.3. Contract Research Organizations |
| 12.5. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. ANZ |
| 12.5.4. Japan |
| 12.5.5. Rest of APAC |
| 12.6. Asia Pacific Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2023 - 2029 |
| 12.7. Asia Pacific Gene Editing Market Dynamics – Trends |
| 13. MEA Gene Editing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 13.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Reagents & Consumables |
| 13.1.2. Software & Systems |
| 13.1.3. Services |
| 13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. CRISPR |
| 13.2.2. TALEN |
| 13.2.3. ZFN |
| 13.2.4. Antisense |
| 13.2.5. Others |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Cell Line Engineering |
| 13.3.2. Genetic Engineering |
| 13.3.3. Diagnostic Applications |
| 13.3.4. Drug Discovery & Development |
| 13.3.5. Others |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Pharmaceutical and Biotechnology Companies |
| 13.4.2. Academic and Research Institutes |
| 13.4.3. Contract Research Organizations |
| 13.5. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1. GCC Countries |
| 13.5.2. South Africa |
| 13.5.3. Rest of MEA |
| 13.6. MEA Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2023 - 2029 |
| 13.7. MEA Gene Editing Market Dynamics – Trends |
| 14. Latin America Gene Editing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 14.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Reagents & Consumables |
| 14.1.2. Software & Systems |
| 14.1.3. Services |
| 14.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. CRISPR |
| 14.2.2. TALEN |
| 14.2.3. ZFN |
| 14.2.4. Antisense |
| 14.2.5. Others |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1. Cell Line Engineering |
| 14.3.2. Genetic Engineering |
| 14.3.3. Diagnostic Applications |
| 14.3.4. Drug Discovery & Development |
| 14.3.5. Others |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1. Pharmaceutical and Biotechnology Companies |
| 14.4.2. Academic and Research Institutes |
| 14.4.3. Contract Research Organizations |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1. Brazil |
| 14.5.2. Mexico |
| 14.5.3. Argentina |
| 14.5.4. Rest of LA |
| 14.6. Latin America Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2023 - 2029 |
| 14.7. Latin America Gene Editing Market Dynamics – Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Merck KGaA |
| 15.2.2. Sangamo |
| 15.2.3. Editas Medicine |
| 15.2.4. Precision Biosciences |
| 15.2.5. CRISPR Therapeutics |
| 15.2.6. Intellia Therapeutics, Inc. |
| 15.2.7. Caribou Biosciences, Inc. |
| 15.2.8. Cellectis S.A. |
| 15.2.9. AstraZeneca |
| 15.2.10. Integrated DNA Technologies, Inc. |
| 15.2.11. Egenesis Inc. |
| 15.2.12. GenScript |
| 15.2.13. OriGene Technologies, Inc. |
| 15.2.14. Lonza |
| 15.2.15. Thermo Fisher Scientific, Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Merck KGaA
- Sangamo
- Editas Medicine
- Precision Biosciences
- CRISPR Therapeutics
- Intellia Therapeutics, Inc
- Caribou Biosciences, Inc.
- Cellectis S.A.
- AstraZeneca
- Integrated DNA Technologies, Inc.
- Egenesis Inc.
- GenScript
- OriGene Technologies, Inc.
- Lonza
- Thermo Fisher Scientific, Inc.